October 24, 2013
Ono Pharmaceutical announced on October 22 that it has entered into a license deal with the US-based Valeant Pharmaceuticals North America LLC, an affiliate of Valeant Pharmaceuticals International Inc. of Canada for the rights to exclusively develop and commercialize metyrosine...read more